4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001209191-21-059038
Options or other derivatives
- Chief Accounting Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Burgess Julie · Chief Accounting Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +135,000 | 135,000 | D |
Loading xslF345X03/doc4.xml…